White Promoted to President of Lilly Oncology

Anne White

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Eli Lilly and Co. has promoted Anne White to senior vice president of Lilly and president of Lilly Oncology. She will become a member of Lilly’s executive committee, reporting directly to Chairman and Chief Executive Officer David Ricks. White succeeds Sue Mahony who retired.

White most recently served as vice president of portfolio management, chorus and next generation research & development. She has more than 25 years of experience in the pharmaceutical industry, serving in leadership roles in oncology, neuroscience, infectious disease drug development and process transformation. White also worked in biotech, having founded and led a startup company in oncology drug development with partnerships with the Moffitt Cancer Center and the National Cancer Institute.

White joined Lilly in 1991 as an engineer before transitioning to clinical research and later oncology drug development both in and outside the company.

She holds a bachelor’s degree in engineering from the University of Michigan. A champion for women in science, she has been recognized for her efforts in mentoring and supporting women in the workplace.